异常性高睡眠症:精神病学实践中的识别和管理
Craig Chepke1,2, Ruth M Benca3, Andrew J Cutler4
1Excel Psychiatric Associates, Huntersville, North Carolina.
The Journal of clinical psychiatry
|June 9, 2025
概括
异常性高睡眠症是一种睡眠障碍,通常在精神病患者中由于高并发症而出现. 早期识别和管理可以改善患者的治疗结果.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
背景情况:
- 异常性高睡眠症是一种中心睡眠障碍,其特点是过度的白天嗜睡 (EDS).
- 它影响到1.5%的人口,并且经常与精神疾病并发症.
- 症状包括睡眠惯性,睡眠时间长,认知问题和自主功能障碍.
研究的目的:
- 审查异常性高睡眠症和精神疾病之间的关系.
- 概述在精神病患者中识别和管理EDS的考虑因素.
- 突出诊断和治疗的挑战.
主要方法:
- 在PubMed和Embase中进行了全面的文献搜索,使用了"异常性高睡眠症"和"精神病"等术语.
- 包括到2024年7月发表的英语人类研究.
- 文章被选为与异常性高睡眠症和精神病患者群体的相关性,通过参考列表搜索.
主要成果:
- 综述中包括了119篇文章.
- 异常性高睡眠症与EDS,睡眠惯性和认知投诉有关,影响多达1.5%的人口.
- 在患有异常性高睡眠症的患者中,观察到高比例的精神病并发症,如情绪障碍和多动性多动症.
结论:
- 精神病学临床医生可能会比其一般患病率更频繁地遇到异常性高睡眠症,因为伴随性疾病.
- 在精神病患者中识别和管理异常性高睡眠症可以提高治疗的有效性.
- 由于精神病药物和异常性高睡眠症治疗之间的潜在相互作用,需要仔细评估.
相关概念视频
Management of Insomnia
328
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
328
Sedatives and Hypnotics Drugs: Miscellaneous Agents
249
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
249
Narcolepsy
205
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
205
CNS Depressants: Barbiturates and Benzodiazepines
484
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
484
Insomnia
133
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
133
Sedatives and Hypnotics: Overview
697
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
697


